Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tuberculosis Treatment Effectiveness”

139 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 139 results

Testing effectiveness (Phase 2)Study completedNCT03982277
What this trial is testing

Safety and Efficacy of High Dose Rifampicin in Tuberculosis (TB)-HIV Co-infected Patients on Efavirenz- or Dolutegravir-based Antiretroviral Therapy

Who this might be right for
Tuberculosis
Makerere University 130
Testing effectiveness (Phase 2)Study completedNCT00910871
What this trial is testing

To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA 241
Large-scale testing (Phase 3)Study completedNCT00023335
What this trial is testing

TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Centers for Disease Control and Prevention 1,000
Not applicableStudy completedNCT00091936
What this trial is testing

Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 592
Testing effectiveness (Phase 2)Study completedNCT00144417
What this trial is testing

TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment

Who this might be right for
Tuberculosis
Centers for Disease Control and Prevention 433
Large-scale testing (Phase 3)Active Not RecruitingNCT06081361
What this trial is testing

Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort

Who this might be right for
Pulmonary TuberculosisRifampicin-resistant Tuberculosis
Beijing Chest Hospital 186
Large-scale testing (Phase 3)Looking for participantsNCT03474029
What this trial is testing

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

Who this might be right for
Latent Tuberculosis
Centers for Disease Control and Prevention 3,400
Not applicableStudy completedNCT00120510
What this trial is testing

Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 816
Large-scale testing (Phase 3)Study completedNCT02581527
What this trial is testing

A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
St George's, University of London 672
Very early researchStudy completedNCT06794502
What this trial is testing

Butterfly Pea Flower (Clitoria Ternatea) for Adjuvant TB Treatment

Who this might be right for
Tuberculosis (TB)Tuberculosis Treatment Effectiveness
Universitas Muhammadiyah Semarang 28
Not applicableUnknownNCT04187469
What this trial is testing

Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB

Who this might be right for
Pulmonary Tuberculosis
Fifth Affiliated Hospital, Sun Yat-Sen University 286
Testing effectiveness (Phase 2)Study completedNCT02237365
What this trial is testing

A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis

Who this might be right for
Tuberculous Meningitis
Oxford University Clinical Research Unit, Vietnam 120
Testing effectiveness (Phase 2)UnknownNCT01638520
What this trial is testing

Safety and Efficacy of Blocking IL-4 With Pascolizumab in Patients Receiving Standard Therapy for Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
National University Hospital, Singapore 32
Large-scale testing (Phase 3)Study completedNCT00341328
What this trial is testing

Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.

Who this might be right for
Tuberculosis
Ministry of Science and Technology, India 300
Not applicableNot Yet RecruitingNCT07731672
What this trial is testing

Incidence of Tuberculosis in Patients With Autoimmune Rheumatic Diseases

Who this might be right for
Autoimmune Rheumatic DiseasesPrevention
University of Sao Paulo General Hospital 1,660
Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Large-scale testing (Phase 3)Study completedNCT03086486
What this trial is testing

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+4 more
Global Alliance for TB Drug Development 181
Large-scale testing (Phase 3)Study completedNCT00023452
What this trial is testing

Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection

Who this might be right for
Tuberculosis
Centers for Disease Control and Prevention 8,053
Not applicableStudy completedNCT01864603
What this trial is testing

Sustainable East Africa Research in Community Health

Who this might be right for
HIVTuberculosisHypertension+3 more
University of California, San Francisco 150,395
Large-scale testing (Phase 3)Study completedNCT02178592
What this trial is testing

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 113
Next Page